The Promotive and Inhibitory Role of Long Non-Coding RNAs in Endometrial Cancer Course-A Review.

carcinogenesis endometrial cancer lncRNA long non-coding RNA

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
03 Jun 2024
Historique:
received: 29 04 2024
revised: 28 05 2024
accepted: 31 05 2024
medline: 19 6 2024
pubmed: 19 6 2024
entrez: 19 6 2024
Statut: epublish

Résumé

Endometrial cancer is one of the most common malignant tumours in women. The development of this tumour is associated with several genetic disorders, many of which are still unknown. One type of RNA molecules currently being intensively studied in many types of cancer are long non-coding RNAs (lncRNAs). LncRNA-coding genes occupy a large fraction of the human genome. LncRNAs regulate many aspects of cell development, metabolism, and other physiological processes. Diverse types of lncRNA can function as a tumour suppressor or an oncogene that can alter migration, invasion, cell proliferation, apoptosis, and immune system response. Recent studies suggest that selected lncRNAs are important in an endometrial cancer course. Our article describes over 70 lncRNAs involved in the development of endometrial cancer, which were studied via in vivo and in vitro research. It was proved that lncRNAs could both promote and inhibit the development of endometrial cancer. In the future, lncRNAs may become an important therapeutic target. The aim of this study is to review the role of lncRNAs in the development of carcinoma of uterine body.

Identifiants

pubmed: 38893244
pii: cancers16112125
doi: 10.3390/cancers16112125
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Auteurs

Patryk Jasielski (P)

Department of Gynecology, Gynecology Oncology and Obstetrics, Fryderyk Chopin University Hospital, 35-055 Rzeszow, Poland.

Izabela Zawlik (I)

Laboratory of Molecular Biology, Centre for Innovative Research in Medical and Natural Sciences, Medical College of Rzeszow University, 35-959 Rzeszow, Poland.
Institute of Medical Sciences, Medical College of Rzeszow University, 35-959 Rzeszow, Poland.

Anna Bogaczyk (A)

Department of Gynecology, Gynecology Oncology and Obstetrics, Fryderyk Chopin University Hospital, 35-055 Rzeszow, Poland.

Natalia Potocka (N)

Laboratory of Molecular Biology, Centre for Innovative Research in Medical and Natural Sciences, Medical College of Rzeszow University, 35-959 Rzeszow, Poland.

Sylwia Paszek (S)

Laboratory of Molecular Biology, Centre for Innovative Research in Medical and Natural Sciences, Medical College of Rzeszow University, 35-959 Rzeszow, Poland.
Institute of Medical Sciences, Medical College of Rzeszow University, 35-959 Rzeszow, Poland.

Michał Maźniak (M)

Department of Gynecology, Gynecology Oncology and Obstetrics, Fryderyk Chopin University Hospital, 35-055 Rzeszow, Poland.

Aleksandra Witkoś (A)

Department of Gynecology, Gynecology Oncology and Obstetrics, Fryderyk Chopin University Hospital, 35-055 Rzeszow, Poland.

Adrianna Korzystka (A)

Department of Gynecology, Gynecology Oncology and Obstetrics, Fryderyk Chopin University Hospital, 35-055 Rzeszow, Poland.

Aleksandra Kmieć (A)

Department of Gynecology, Gynecology Oncology and Obstetrics, Fryderyk Chopin University Hospital, 35-055 Rzeszow, Poland.

Tomasz Kluz (T)

Department of Gynecology, Gynecology Oncology and Obstetrics, Fryderyk Chopin University Hospital, 35-055 Rzeszow, Poland.
Institute of Medical Sciences, Medical College of Rzeszow University, 35-959 Rzeszow, Poland.

Classifications MeSH